DR AKASH PATEL View Full Profile
DR ARCHIT JOSHI View Full Profile
DR BHAVISHA GHUGARE View Full Profile
DR GANPATHI BHAT View Full Profile
DR GAURANG MODI View Full Profile
DR GURSEV SANDLAS View Full Profile
DR INDOO AMBULKAR View Full Profile
DR ITESH KHATWANI View Full Profile
DR JAYESH PRAJAPATI View Full Profile
DR RANDEEP SINGH View Full Profile
DR RUSHABH KOTHARI View Full Profile
DR RUSHIT SHAH View Full Profile
DR SHAILESH SHAH View Full Profile
Throughout the years, cancer research has adapted and grown, as knowledge around the different diseases has become more understood. Important advances have been made by scientists, of which some are oriented around finding better treatments for patients. In the past, the location of the tumour was the only aspect considered when determining a treatment pathway, however scientists and physicians were unable to find a standard regimen for every patient of a given type of cancer.
As understanding and research has progressed, it is now known that both the nature and determining features of the tumour, as well as location, influence the effectiveness of the treatment. In addition to this growing understanding, new discoveries regarding the molecular mechanisms of drug responses, have given a new dimension to the research.
In spite of the many scientific advances, most cancer treatment decisions still continue to rely on population based research findings. Today, when physicians recommend chemotherapy as the treatment pathway, they are the ones who determine which drugs should be used. In chemotherapy treatment, it is common that more than one drug is necessary to attack each tumour. In order to determine what drug or drug combinations to use, physicians take into consideration the results of a variety of tests such as blood tests, physical examinations and medical history of the patient.
If you have any patient to receive chemotherapy after being diagnosed with cancer, you should be glad to know that CLYZ Labs has launched CanCertain test to choose the active drugs for each individual. CanCertain test by CLYZ Labs can help the physicians plan the most accurate treatment. CanCertain is the 3D based cell culture analysis. 3D based analysis mimics the natural human environment in the laboratory so it provides the most efficacious personalized treatment plan.
In CanCertain test, our scientists find the most accurate treatment therapy for the individual patient so cancer can be cured in the shortest possible time avoiding side effects of unnecessary drugs.
In CanCertain test, sensitivity is found by determining the level of effectiveness of certain chemo-agents against cancer cells of the individual patient. Contrarily, the results of the Chemo-sensitivity test also determine the drug resistance which means offering information about which cancer cells of the patient continue living and growing despite receiving the drug.
With the results of this test, the patients do not need to go through a “guess and check” treatment with the drugs and they can protect their immune system from the beginning of the treatment. In this sense, CanCertain test can help physicians to personalize the treatment by choosing the chemo-agent, regimen and other biological elements that better suit every patient.
Going through chemotherapy is not an easy task for anyone and many efforts have been oriented to light the physical, emotional, psychological and financial burden it brings to the patient. CanCertain test by CLYZ Labs can contribute to diminish such burden and improve the quality of life of the patient during the treatment.
Taking the CanCertain test will be easy and fast. Fresh Blood sample and Fresh samples from solid or fluid tumours will be obtained from the biopsy or surgery of the patient. Those samples will be sent to the CLYZ Labs to conduct CanCertain Test with a variety of chemotherapy drugs along with the blood test. Test results will be available in 7 -10 days before your clinic visit. Sensitivity is found by determining the level of effectiveness of certain chemo-agents against cancer cells of the patient. In the opposite way, the results of CanCertain test also determine the drug resistance which means offering information about which cancer cells of the patient continue living and growing despite receiving the drug. With the results of CanCertain test, the patients do not need to go through a “guess and check” treatment with the drugs and they can protect their immune system from the beginning of the treatment.
The CanCertain test will be suitable for any patient diagnosed with cancer at any stage of the disease. Those who take the test before starting the first treatment will be most benefitted. If the patient already started a chemotherapy treatment, the test would still be able to improve such treatment and find new alternatives if necessary.
Recommended treatment based on CanCertain test will improve the quality of life of the patient by providing the most accurate treatment, save time and money not spending on guess based treatment and avoids side effects of unnecessary drugs.